| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B59-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 |
| filingDate |
2015-12-15^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-01-30^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ca498cc5b86a7878ce26dd4061072da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6beb9c943987dd9e3a44604b32a2fd47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_141cf82bc358b7f5f09efab58a5f34fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1e95c376fd0418f3d3023c6b5a31049
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e07af0f0ccfa14c86119101971b9f48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d01101713ec8ee1ff365a04635114542 |
| publicationDate |
2018-01-30^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9879029-B2 |
| titleOfInvention |
ERK inhibitors |
| abstract |
The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer. |
| priorityDate |
2014-12-22^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |